A proposal for reducing the effect of one of many causes of publication bias

Trials

Julie A Burrett¹  Sue M Richards¹ 

[1] Clinical Trial Service Unit (CTSU), Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LF, UK

关键词: Venesection;    Radioactive phosphorous;    Busulphan;    Polycythaemia;    Randomized trial;    Publication bias;   

Others  :  1094795
DOI  :  10.1186/1745-6215-14-41

 received in 2012-03-26, accepted in 2013-01-28,  发布年份 2013

【 摘 要 】

In order to avoid publication bias, all trials should be registered at initiation and their results made easily accessible. However, some trial results are more difficult to publish than others. This report describes one such trial and highlights the need for a way of making results of trials widely available even if not presented in the traditional format. Until such time as it is required by law both to register all trials and enter their final results into the database, a lack of resources will mean that some trial results are never published. The scale of the problem of non-publication is unknown and for valid trial results any form of publication is better than none. Therefore it is essential that a quick and easy way is available to act as a safety net to catch trial results that would otherwise be lost.

【 授权许可】

   
2013 Richards and Burrett; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Begg CB, Berlin JA: Publication bias: a problem in interpreting medical data. J Roy Stat Soc A 1988, 151:445-463.
• [2]Dickersin K: The existence of publication bias and risk factors for its occurrence. JAMA 1990, 263:1385-1389.
• [3]Dickersin K, Min YI, Meinert CL: Factors influencing publication of research results. Follow up of applications submitted to two institutional review boards. JAMA 1992, 267:374-378.
• [4]Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR: Publication bias in clinical research. Lancet 1991, 337:867-872.
• [5]Dwan K, Altman DG, Arnalz JA, Bloom J, Chan A-W, Cronin E, Decullier E, Easterbrook PJ, von Elm E, Gamble C, Ghersi D, Ioannidis JPA, Simes J, Williamson PR: Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008, 3:e3081.
• [6]Burrett JA, Lunn D: Analysis of characteristics of randomized clinical trials in leukaemia that are associated with how results are reported. JEBM 2011, 4:217-224.
• [7]Paulson K, Saeed M, Mills J, Cuvelier GDE, Kumar R, Raymond C, Robinson T, Szwajcer D, Wall D, Seftel MD: Publication bias is present in blood and marrow transplantation: an analysis of abstracts at an international meeting. Blood 2011, 118:6698-6701.
• [8]Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, Alonso-Coello P, Djulbegovic B, Atkins D, Falck-Ytter Y, Williams JW Jr, Meerpohl J, Norris SL, Akl EA, Schünemann HJ: GRADE guidelines 5: rating the quality of evidence - publication bias. J Clin Epidemiol 2011, 64(12):1277-82. Dec, Epub 2011 Jul 30
• [9]De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJPM, Schroeder TV, Sox HC, Van Der Weyden MB: Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 2004, 364:911-912.
• [10]Ross JS, Mulvey GK, Nissen SE, Krumholz HM: Trial publication after registration in ClinicalTrials.gov: a cross-sectional analysis. PLoS Med 2009, 6(9):e1000144.
• [11]Tuma RS: New law may be having some effect on publication bias. JNCI 2010, 102:290-292.
• [12]Bian Z-X, Wu T-X: Legislation for trial registration and data transparency. Trials 2010, 11:64-66. BioMed Central Full Text